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Abstract
Background: G protein-coupled receptors represent a large family of eukaryotic membrane proteins, and are involved in
almost all physiological processes in humans. Recent advances in the crystallographic study of these receptors enable a
detailed comparative analysis of the commonly shared heptahelical transmembrane bundle. Systematic comparison of the
bundles from a variety of receptors is indispensable for understanding not only of the structural diversification optimized for
the binding of respective ligands but also of the structural conservation required for the common mechanism of activation
accompanying the interaction changes among the seven helices.
Methodology/Principal Findings: We have examined the bundles of 94 polypeptide chains from almost all available
structures of 11 receptors, which we classified into either inactivated chain or activated chain, based on the type of bound
ligand. For the inactivated chains, superposition of 200 residue bundles by secondary structure matching demonstrated that
the bound ligands share a laterally limited cavity in the extracellular section of the bundle. Furthermore, a distinct feature
was found for helix III of bovine rhodopsin, which might have evolved to lower its activity in the presence of 11-cis-retinal,
to a level that other receptors could hardly achieve with any currently available ligands.
Conclusions/Significance: Systematic analysis described here would be valuable for understanding of the rearrangement of
seven helices which depends on the ligand specificity and activation state of the receptors.
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Introduction
G protein-coupled receptor (GPCR) mediates signal transduc-
tion through the cell membrane by activating many copies of
cognate heterotrimeric G protein upon binding of an agonist [1].
GPCRs form a large superfamily of heptahelical transmembrane
(7TM) proteins and function universally across the eukaryotic
organisms [2]. A majority of the GPCR superfamily is grouped
into the class A (rhodopsin-like) family which shares a handful of
amino acids in the 7TM region. Crystallographic studies have
made extensive progress in solving structures for the class A
GPCRs for biogenic amines, including turkey b1 and human b2
adrenergic receptors, human dopamine D3 receptor, human
histamine H1 receptor, and most recently, human M2 and rat M3
muscarinic acetylcholine receptors [3,4]. Other GPCRs of known
structure are bovine and squid rhodopsins, human A2A adenosine
receptor, human CXCR4 chemokine receptor and human S1P1
receptor (Sphingosine 1-phosphate receptor 1) [5].
The orthosteric ligand binding site of the class A GPCRs mainly
consists of residues within the 7TM bundle. Although accumulat-
ing crystallographic evidence has proved that the arrangements of
helices in the 7TM bundle of these receptors are very similar to
each other, it remains unclear whether a particular receptor group
has unique features in the backbone trace of the 7TM region.
Therefore, the manner in which these seven helices are able to
discriminate ligands among the class A GPCRs is a fundamental
issue to be investigated in detail. Although the experimental
structures of GPCRs have been extensively reviewed [6,7] and it is
common for some pairwise comparisons to be described when a
new structure appears, there are few systematic surveys of 7TM
structures.
The structures in the presence of the inactivating ligand
(antagonist, inverse-agonist) have been obtained for all the
receptors described above. The agonist bound and/or ligand free
structures have also become available for bovine rhodopsin, b1
and b2 receptors and A2A receptor [8]. However, some of the
agonist bound structures assume inactive-like conformations [9],
indicating that the structural equilibrium between the inactive and
active forms of a receptor is determined by complex mechanisms.
After selecting and aligning the 7TM bundles of all available
crystal structures, we performed an extensive analysis of the
inactivated (antagonist bound or inverse-agonist bound) forms and
found that bovine rhodopsin has a distinct rigid-body arrangement
of helix III that might contribute to its extremely low activity
without light stimulation. The implications of the present analyses
are also discussed with regard to the studies of activation
mechanisms and the modeling of rhodopsin-like receptors of
unknown structure.
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First, we tabulated almost all the crystallographic PDB entries
for bovine and squid rhodopsins, b1 and b2 receptors, A2A
receptor, CXCR4 receptor, D3 receptor, H1 receptor, M2 and
M3 receptors and S1P1 receptor, excluding redundant entries with
lower resolution. Each polypeptide chain in an entry was
considered separately, giving a total of 94 chains. Then, they
were classified into two categories: an inactivated group (antag-
onist bound, inverse-agonist bound) and an activated group
(agonist bound, ligand free), containing 62 and 32 chains,
respectively. This classification is solely based on the type of
ligand binding and does not necessarily mean that each chain in
the activated group substantially differs with respect to the
backbone structure from the inactivated group. Since current
analyses mainly focus on the inactivated chains, it is important to
ensure that the inactivated group does not contain any chains of
agonist-bound, inactive-like structures. A complete list of the
chains is shown in Table S1 of the Supporting Information, and
also available at a new web site http://www.gses.jp/7tmsp/.
According to multiple sequence alignments performed at
GPCRDB (http://www.gpcr.org/7tm/), each of the polypeptide
chains was processed to make a 7TM bundle consisting of 200
residues, which is intermediate in size between that described for
bovine rhodopsin [10] and b2 receptor [11]. Although there are
no universally accepted criteria to define the 7TM bundle, the
well-conserved lengths of the first and third extracellular loops and
the first and second cytoplasmic loops in class A GPCRs leave little
arbitrariness in the choice for the range of each helix. At this stage,
12 chains of the inactivated form and 2 chains of the activated
form were found to be ,200 residues in size, and were not
processed further.
The range of each helix contained in a bundle is shown in the
footnote of Table 1. The bundle of 200 residues chosen in this
work does not exactly correspond to the region buried within the
expected membrane thickness. For instance, the carboxyl termini
of helices III and V, and the amino terminus of helix VI protrude
past the cytoplasmic membrane surface. It is important to include
these cytoplasmic regions as parts of the bundle, because they are
supposed to regulate both the constitutive and ligand-induced
activities of the receptors [7–9]. The length of helix I is currently
limited by the availability of the coordinates, and the segment
analyzed is probably shorter than the thickness of the membrane.
All of the 200 residue 7TM bundles were superposed on that of
the highest resolution inactivated form of b2-adrenergic receptor
(PDB entry 2RH1) by a secondary structure matching (SSM)
algorithm [12] implemented in Coot [13], from which 10
representative chains are shown in Figure 1. Different choices of
the reference bundle to which all the others were fit did not affect
the results of the current analysis.
Using 9 representative chains (1U19-A for bovine rhodopsin,
2Z73-A for squid rhodopsin, 2RH1 for b2 receptor, 3EML for
A2A receptor, 3ODU-A for CXCR4 receptor, 3PBL-A for D3
receptor, 3RZE for H1 receptor, 3UON for M2 receptor and
3V2Y for S1P1 receptor), deviations at 200 positions were
calculated for all possible 36 pairs by CCP4 [14], demonstrating
that the SSM fitting worked well because the Ca atoms of highly
conserved residues (such as *.50s of Ballesteros & Weinstein
numbering [15] for GPCRs, in which * is to be replaced with the
number of helix) exhibited very small shifts among the chains from
different receptors (Figure 2). For instance, an arginine residue
(3.50) in the highly conserved D/ERY motif at the cytoplasmic
end of helix III (Figure S1b, Supporting Information) exhibits an
averaged deviation of 1.05 A ˚ for the Ca position. On the other
hand, the Ca of a glutamate residue (6.30) that was supposed to
form the so-called ‘‘ionic lock’’ with the arginine residue (3.50)
significantly differs (3.24 A ˚) between receptors. In fact, such an
‘‘ionic lock’’ is present only in 3 (bovine and squid rhodopsins, D3
receptor) out of 10 representative chains (2 chains do not have
Glu/Asp at 6.30). These results indicate that SSM fitting clearly
differentiates the conserved region from the variable region of the
receptors. This finding is particularly important because it implies
that fitting of the chains in the activated group to an inactivated
reference is also appropriate to enable reasonable comparisons, as
described later.
Overall similarity of the backbone traces from 10 receptors was
then examined by rmsd calculation after superposition with the
SSM algorithm. Using 50 chains (11 of bovine rhodopsin, 5 of
squid rhodopsin, 5 of b2 receptor, 12 of b1 receptor, 6 of A2A
receptor, 5 of CXCR4 receptor, 2 of D3 receptor, 1 of H1
receptor, 1 of M2 receptor and 2 of S1P1 receptor) of the
inactivated form, 1225 pairwise values could be obtained.
However, 7 chains of b1 receptor were excluded because they
deviated substantially from other chains at the N-terminal part of
helix I [16] or helix VI [17].
Then, from the remaining 43 chains, all 903 pairwise rmsd
values were grouped into 53 receptor pairs and averaged for each
Table 1. Averaged rmsds (A ˚) of the 7TM bundle pairs in the inactive state for class A GPCRs of known structure.
brh srh b2 A2A CXCR4 D3 H1 M2 S1P1
brh 0.63 (100)
srh 1.64 (30.0) 0.29 (100)
b2 1.94 (21.5) 1.92 (25.5) 0.33 (100)
A2A 2.41 (23.5) 2.34 (23.5) 2.00 (35.5) 0.60 (100)
CXCR4 2.39 (22.0) 2.39 (21.5) 2.51 (24.0) 2.70 (22.0) 0.71 (100)
D3 1.79 (28.0) 1.71 (20.5) 1.46 (38.0) 1.60 (32.5) 2.21 (27.5) 0.57 (100)
H1 2.00 (20.0) 1.99 (23.0) 1.47 (36.5) 2.02 (34.0) 2.29 (25.0) 1.46 (35.5)
M2 2.37 (22.5) 2.46 (20.5) 1.55 (29.5) 2.28 (27.0) 2.65 (23.0) 1.95 (33.0) 1.81 (37.5)
S1P1 2.55 (21.5) 2.54 (23.5) 2.06 (27.0) 1.99 (29.5) 2.78 (22.0) 1.94 (26.5) 2.16 (24.5) 2.34 (27.0) 0.40 (100)
Amino acid sequence identity (%) is also shown in parenthesis. The range of each helix contained in a 200 residue 7TM bundle with Ballesteros & Weinstein numbering
is as follows: helix I, 1.35–1.59 (25 a.a.); helix II, 2.38–2.67 (30 a.a.); helix III, 3.22–3.55 (34 a.a.); helix IV, 4.39–4.63 (25 a.a.); helix V, 5.36–5.65 (30 a.a.); helix VI, 6.29–6.60 (32
a.a.); helix VII, 7.32–7.55 (24 a.a.). brh and srh stand for bovine rhodopsin and squid rhodopsin, respectively.
doi:10.1371/journal.pone.0035802.t001
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PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35802Figure 1. Stereo view of molecular overlay of 10 representative 7TM bundles of inactivated GPCRs of known structure. a) The
extracellular side is facing upward while helix I is shown on the left. b) The 7TM bundles are viewed from the bottom of a). Seven highly conserved
residues (*.50 s) are shown on the Ca backbone traces. The colors of receptors are red, bovine rhodopsin (1U19-A); pink, squid rhodopsin (2Z73-A);
blue, b2 receptor (2RH1); cyan, b1 receptor (2VT4-B); yellow, A2A receptor (3EML); gray, CXCR4 receptor (3ODU-A); magenta, D3 receptor (3PBL-A);
purple, H1 receptor (3RZE); green, M2 receptor (3UON); light green, S1P1 receptor (3V2Y).
doi:10.1371/journal.pone.0035802.g001
Figure 2. Averaged displacement (A ˚)o fC a atoms of 200 residues. Thirty-six pairwise deviations at each position were averaged and plotted
against a serial number of residues in a 7TM bundle. The residues located in the same section (slab) are colored in red, section 1; pink, section 2;
green, section 3; cyan, section 4; blue, section 5. The borders between the adjacent helices are shown with gray bars at the top of the panel, while the
positions of seven *.50 residues are shown with short black bars near the zero line of the graph.
doi:10.1371/journal.pone.0035802.g002
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For instance, an averaged rmsd among 11 chains of bovine
rhodopsin was calculated to be 0.63 from 55 values. This value
and others could have been even lower had we considered stricter
criteria, such as excluding some chains of lower resolution
structure. The standard deviations of the averaged values are less
than 0.1 A ˚, except for brh-brh, srh-srh, b1-b1, A2A-A2A,
CXCR4-CXCR4 pairs, indicating that the rmsds obtained
between different receptors did not vary so much. It should be
noted that the rmsd values shown here include the effect of
mismatches between the amino acid sequence and structural
alignments. Comparison of each helix indicated that such
mismatches arose at helix II with CXCR4 receptor [7] and squid
rhodopsin. Current analysis of the 7TM bundles also suggests that
there are some other regions, including the extracellular side of
helix IV [7], for which it is still difficult to determine if a large
deviation for a particular receptor results either from the
deformation of the helical structure or from the insertion/deletion
of a single residue.
To reveal structural features of a receptor in terms of ligand
binding specificity, sectional comparisons were performed for 10
receptors. Stability and diversity of 7TM structure vary among the
sections stacked along the normal to the membrane plane [7,18].
According to previous electron microscopic observation on two-
dimensional crystals of bovine rhodopsin [19], it is reasonable to
assume that the axis of helix IV is almost perpendicular to the
membrane plane. In addition, secondary structure analysis by
DSSP [20] indicated that helix IV of both adrenergic receptors
and M2 receptor contains canonical a-helical turns throughout the
25 residues in the 7TM bundle.
Therefore, we divided a 7TM bundle into 5 sections,
corresponding to 5 residues of helix IV per section (Figure S1,
Supporting Information). Each section had similar thickness
(about 7.5 A ˚) along the normal to the membrane plane, except
sections 1 and 5 corresponding to the extracellular and
cytoplasmic surface layers, respectively. Because of the different
lengths of some helices, as mentioned above, neither of these 2
sections had a flat surface. The range of amino acid sequences of
the 7 helices chosen in each section is summarized in Table S2 of
the Supporting Information. The boundaries between sections 2/
3, 3/4, and 4/5 are similar to those described previously [18].
Because section 1 is the most relevant region as the binding path
for diffusible ligands from the extracellular space, one might
expect that deviation among the receptors should be larger than
for the other sections. This was found to be the case for most of the
pairwise combinations, except for the pairs of adrenergic receptors
and muscarinic receptors. The low rmsds between muscarinic and
adrenergic receptors in this section are remarkable, especially
compared with that of the other sections (see Table S3, Supporting
Information).
In spite of the larger backbone deviation in section 1, the
position of the bound ligand in each receptor is restricted within an
overlapping space between helices II and V (Figure 3a). On the
other hand, the ligand position varies significantly along the
normal to the membrane plane. The ligands of rhodopsin, H1
receptor and M2 receptor reach down to the space corresponding
to section 2, while the ligand of A2A receptor extends up to the
extracellular surface of the 7TM bundle (Figure 3b).
The pocket for the ligands shown in Figure 3 is mostly
composed of the side chains of section 1. However, we noticed that
a short backbone trace of helix III of bovine rhodopsin was also
visible. To clarify the unique arrangement of bovine rhodopsin in
this region, a molecular overlay of the Ca trace of sections 1 and 2
of the representative chains of 10 receptors is shown in Figure 4.
The most remarkable finding is that only the Ca backbone of
bovine rhodopsin deviates significantly from the middle to the
extracellular side of helix III, roughly from 3.27 to 3.36. This
feature was prominent even after overlaying all 50 inactivated
chains. The most closely related GPCR of known structure, squid
rhodopsin was slightly closer to bovine rhodopsin but only from
3.27 to 3.31. In addition, no chains deviated by as many as 3
helical turns toward the inside of the 7TM bundle at any of the
other helices.
Position 3.36 is close to the boundary between sections 2 and 3,
where deviations among the receptors were quite small (Figure 2).
A unique feature of vertebrate rhodopsin in the amino acid
sequence of helix III is the presence of Glu113 (3.28), the
counterion to the protonated 11-cis-retinal Schiff base, the intrinsic
inverse-agonist covalently bound to the side chain of Lys296 (7.43).
The salt-bridge between Schiff base proton and deprotonated side
chain of Glu113 is one of the constraints that force the protein
moiety to be quiescent [21]. We suppose that acquisition of an
Figure 3. Molecular overlay of section 1 of 10 representative
chains of inactivated GPCRs of known structure. All the
polypeptides (thin lines) and bound ligands (thick lines) are viewed
(a) perpendicularly (from the cytoplasmic side) or (b) horizontally (from
the top of a), parallel to the membrane). Backbone ribbons of b2
receptor are also shown to clarify the position of the 7 helices. Colors of
the side chains and ligands of each receptor are the same as in Figure 1.
The Ca backbone trace of bovine rhodopsin is marked with a red
asterisk in a).
doi:10.1371/journal.pone.0035802.g003
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responsible for the structural rearrangement of TM3 in vertebrate
rhodopsin because invertebrate squid rhodopsin does not have
glutamate or aspartate at this position.
Secondary structure analysis indicated that helix III adopts a
regular a-helical structure with no obvious kink in each of the 10
receptors. Both bovine and squid rhodopsins have a Gly-Gly
sequence in the middle of this helix although the position is shifted
roughly 1 turn toward the extracellular side in squid rhodopsin.
The tandem glycine, however, is not the cause of inward shift of
helix III in rhodopsin because when this helix was analyzed in
isolation, its shape was nearly invariant across receptors (Figure
S2, Supporting Information). Thus the deviation in rhodopsin
represents a rigid-body rearrangement within the 7TM bundle.
The inward displacement in the middle of helix III of
inactivated bovine rhodopsin appears to have another implication
in terms of photoactivation. Previous low temperature crystallo-
graphic studies trapping the early photoreaction intermediates
demonstrated that the absorbed photon energy is initially stored in
bathorhodopsin which is observable transiently in pico- to
nanoseconds at room temperature and has a highly distorted all-
trans-retinal chromophore [22]. Then during the thermal relaxa-
tion process of bathorhodopsin in nano- to microseconds, the
energy is transmitted to the protein moiety as an outward
deformation in the middle of helix III [23].
Considering the current analysis of backbone structure, it would
be possible to conclude that the inward displacement of helix III in
the mid to extracellular sections makes rhodopsin more con-
strained than the other GPCRs. In fact, the 7TM bundles of
bovine rhodopsin with all-trans-retinal agonist bound (a mimic of
the physiologically active intermediate formed in milliseconds)
exhibit an arrangement of helix III similar to that observed in
other GPCRs (Figure 4b). It should be also noted that, in addition
to lateral displacement discussed here, a small backbone shift along
the axis of helix III could contribute to the activation of rhodopsin,
as described for A2A receptor [8] and discussed below.
Discussion
To initiate the process of rhodopsin activation, photon energy is
required to push the middle of helix III transiently out to a position
similar to that observed in the other receptors. Conversely, such a
primary process is not necessary for other receptors whose basal
activity is not quenched to the exceptionally low level achieved in
bovine rhodopsin. It is also possible that the distinct feature of the
ligand binding sections in bovine rhodopsin correlates with the
stability of the inactive conformation at the cytoplasmic surface. In
this respect, it is particularly important to consider the presence of
the D/ERY motif near the cytoplasmic end of helix III.
As noted above, the Ca position of the arginine (3.50) in this
motif deviates only an average of 1 A ˚ among all the receptor pairs
of known inactive structures. Furthermore, Figure 2 indicates that
the deviations in this motif are exceptionally small among the
residues located in section 5 (colored blue). These findings are
consistent with the idea that the position of this motif is critical for
the activation of rhodopsin-like GPCRs.
The present study provides valuable information to enable a
general scheme of activation to be drawn, because all the chains
under consideration have identical helix lengths and are
superposed on a single common reference chain. Although it has
become evident that a major structural change in the 7TM bundle
induced upon activation is the rigid-body movement of helix VI
[24,25] resulting in the binding of trimeric G protein [26],
considerable variation was observed in the magnitude of the
positional change of the cytoplasmic terminal residues of this helix
(Figure S3, Supporting Information) depending on both the type
of receptor and the presence of stabilizing partner such as
nanobody [27] and trimeric Gabc [26]. The smaller changes in
the cytoplasmic regions of helix V and VII, previously proposed to
accompany activation [8], do not appear to be consistent among
the receptors (bovine rhodopsin, b2 receptor and A2A receptor)
for which both inactivated and activated chains are available.
As mentioned above, a small axial translation of helix III
appears to occur toward the extracellular side upon activation of
bovine rhodopsin and A2A receptor, and this is also consistent
with the change observed for the b2 receptor based on the present
superposition. Therefore, it appears possible that the axial shift of
helix III and the large rigid body movement of helix VI are
structurally linked in these receptors. It is noteworthy that
mutations affecting the interaction between helices III and VI
Figure 4. Projection view (from the cytoplasmic side) of
molecular overlay of sections 1 and 2. a) 10 representative chains
of inactivated GPCRs. b) the same inactive chains plus 2 chains of
activated bovine rhodopsin. The colors in a) are the same as in Figure 1.
In b), 1 inactivated chain (1U19-A) and 2 activated chains of bovine
rhodopsin (PDB ID: 3PQR and 3PXO) are shown in red and black,
respectively, while other chains are shown in gray.
doi:10.1371/journal.pone.0035802.g004
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GPCRs. Such mutations have been found not only at the
cytoplasmic surface sites, which possibly affects the ionic-lock
between Arg(3.50) and Glu(6.30), but also at the middle of these
helices [28,29]. The latter findings are consistent with the recent
proposal that the activation of b2 receptor accompanies a relative
position change between the residues of helix III (3.40) and VI
(6.44) interacting with each other [27]. The present analysis
indicates that a similar change also occurs in bovine rhodopsin and
A2A receptor between the residue at 3.36 and a conserved
tryptophan (6.48). Exceptionally low activity of bovine rhodopsin
would result, at least partly, from the unique rigid-body
arrangement of helix III as demonstrated above, which would
restrict the movements of these residues and the bound inverse-
agonist 11-cis-retinal. In summary, stabilization of the interface
between helices III and VI at the central part of the
transmembrane region is likely to suppress the movement of these
helices, and thereby, restrain the cytoplasmic surface of receptor to
the inactive conformation.
The present method can easily be applied to survey the growing
number of experimental structures of rhodopsin-like GPCRs. In
addition, it will aid other computational studies, such as simulation
of the activation process and homology based modeling of the
receptors with unknown structure, by providing some statistical
constraints on the positional deviation allowed for each of the
residues in the 7TM bundle during the calculations. For example,
further accumulation of experimental structures of a variety of
activated receptors would highlight certain regions within the
bundle that exhibit little positional differences before and after
activation. Subsequently, the identified regions would be treated as
a common scaffold during simulation of the activation process.
Similarly, the data of the positional deviations among the
receptors, when combined with the data of sequence identities
and/or similarities, is beneficial for modeling the 7TM bundles of
receptors that have not yet been crystallized. For these
applications, it is also important to identify and consider the
possible contribution of internal hydrogen bonds including the
water molecules conserved among the receptors [30,31].
Note Added in Proof
After revision of this paper, four new entries (five chains) in the
PDB have been released, namely, two inactivated chains of human
kappa opioid receptor (PDBID: 4DJH), one inactivated chain of
mouse mu opioid receptor (4DKL), and two inactivated chains of
A2A receptor (3UZA, 3UZC). These structures confirm the
findings described in this paper. Updates to Table 1 and Tables
S1, S2, and S3 are available at http://www.gses.jp/7tmsp/.
Materials and Methods
Crystallographic entries for GPCRs were obtained from Protein
Data Bank. They were classified into two categories: an inactivated
group (antagonist bound, inverse-agonist bound) and an activated
group (agonist bound, ligand free). After separating the polypep-
tide chains from the entries, SSM superposition was performed
with Coot [13] for the representative inactivated chains of several
receptors. Then, the range of each helix consisting of a 7TM
bundle was determined as shown in the footnote of Table 1,
guided by the results of multiple sequence alignment performed at
GPCRDB. A 7TM bundle of 200 residues was successfully
extracted from 80 chains and superposed on that of the highest
resolution inactivated form of b2-adrenergic receptor (PDB entry
2RH1).
Rmsds were calculated with Discovery Studio Visualizer
(Accelrys Inc.). The values were identical to that obtained with
Chimera [32]. Deviations at 200 residue positions were calculated
by CCP4 [10] for all possible 36 pairs of 9 receptors. b1 receptor
was not considered because its backbone structure is quite similar
to that of b2 receptor, as shown in Table S3 of Supporting
Information. Secondary structure of each receptor was analyzed
by DSSP [20]. Figures 1, 3, 4, S1, S2 and S3 including the parallel
(wall-eye) stereo pictures were prepared using CCP4MG [33].
Supporting Information
Figure S1 Sectional comparison of 7TM bundles. a)
Stereo view of molecular overlay of 5 sections from 10
representative chains of inactivated GPCRs. Ca traces are viewed
from the same direction as Figure 1a. b) Snake model of 7TM
bundle showing the range of residues in 5 sections. Two to three
Ballesteros & Weinstein numbers are shown for each helix. The
position of *.50 residue in each helix and of the D/ERY motif in
helix III are indicated with a thick circle and a white rectangle,
respectively. The colors of five sections are the same as in Figure 2.
(TIF)
Figure S2 Comparison of helix III. a) Stereo view of
molecular overlay of helix III within 7TM bundles of the
representative chains of 10 receptors: bovine rhodopsin (red),
squid rhodopsin (pink), b2 receptor (blue), b1 receptor (cyan), A2A
receptor (yellow), CXCR4 receptor (grey), D3 receptor (magenta),
H1 receptor (purple), M2 receptor (green) and S1P1 receptor (light
green). b) Stereo view of molecular overlay of isolated helix III
from the representative chains of 10 receptors after superposition
to isolated helix III of b2 receptor.
(TIF)
Figure S3 Comparison of structural change of helix VI.
Stereo view of molecular overlay of helix VI within 7TM bundles:
inactivated (red, PDB ID: 1U19-A) and activated (pink, PDB ID:
3PXO) bovine rhodopsin, inactivated (blue, PDB ID: 2RH1) and
activated (cyan, PDB ID: 3SN6) b2 receptor, inactivated (yellow,
PDB ID: 3EML) and activated (lemon, PDB ID: 3QAK) A2A
receptor.
(TIF)
Table S1 Full list of the chains considered. The chains
used in this work are shown as 200 in the 7TM column.
Abbreviations Ab: antibody bound, Nb: nanobody bound, T4L:
T4 lysozyme merged.
(DOC)
Table S2 The range of amino acid sequences of 7
helices chosen in 5 sections. Each of H, s, e, BW, brh and
srh stands for helix number, start residue number, end residue
number, Ballesteros & Weinstein number, bovine rhodopsin and
squid rhodopsin, respectively.
(DOC)
Table S3 Sequence identity, similarity and rmsd among
the representative chains of 10 receptors, for all 200
residues and for each of 5 sections.
(DOC)
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